Alk-Abello AS (CHIX:ALKBC) Institutional Ownership: 22.27% (As of Jul. 11, 2026)


CHIX:ALKBC Alk-Abello AS CHIX:ALKBC
92 GF Score
Price kr256.30
GF Value kr207.94
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Alk-Abello AS Institutional Ownership?

Alk-Abello AS CHIX:ALKBC 92 Institutional Ownership is 22.27% as of Jul. 11, 2026. GuruFocus rates CHIX:ALKBC with a GF Score™ of 92/100 and a GF Value™ of kr207.94 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Alk-Abello AS's institutional ownership is 22.27%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Alk-Abello AS's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Alk-Abello AS's Float Percentage Of Total Shares Outstanding is 0.00%.

Alk-Abello AS Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Alk-Abello AS's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alk-Abello AS Institutional Ownership Chart

Alk-Abello AS Historical Data

The historical data trend for Alk-Abello AS can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 22.31 22.05 22.01 22.03 21.83 21.50 21.11 21.82 22.28 22.27
CHIX:ALKBC
92GF Score
Alk-Abello AS CHIX:ALKBC
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alk-Abello AS Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 22.27% mean?
Alk-Abello AS (CHIX:ALKBC) has a Institutional Ownership of 22.27% as of Jul. 11, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Alk-Abello AS and its competitors.
Is Alk-Abello AS's Institutional Ownership too high?
Alk-Abello AS's current Institutional Ownership is 22.27%. Overall, Alk-Abello AS has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Institutional Ownership compare to VRTX and REGN?
Alk-Abello AS's Institutional Ownership of 22.27% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current Institutional Ownership is 22.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (CHIX:ALKBC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr207.94, compared to a current price of kr256.30 — trading 23.3% above its estimated fair value. The current Institutional Ownership is 22.27%. Alk-Abello AS's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Alk-Abello AS (CHIX:ALKBC), the current Institutional Ownership is 22.27% as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alk-Abello AS (CHIX:ALKBC) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of kr256.30 is trading 23.3% above its estimated GF Value™ of kr207.94. GuruFocus considers Alk-Abello AS to be Modestly Overvalued.

Key valuation signals for CHIX:ALKBC:

  • Institutional Ownership: 22.27%
  • GF Value™: kr207.94 vs. price of kr256.30 (23.3% above fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the CHIX:ALKBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
92GF Score

Get the complete analysis for CHIX:ALKBC

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr256.30
Price
kr207.94
GF Value